Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LumiMeds vs ReadyRx

LumiMeds
Graded #143

Higher grade

vs+0.7999999999999972
ReadyRx
Graded #156

Lower grade

The verdict

LumiMeds takes it — 68.6/100 to 67.8/100, but only just.

LumiMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider with flat-rate compounded GLP-1 pricing on a 3-month plan. ReadyRx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLumiMeds +16
77
61
Dose & formulationEven
64
64
Clinical oversightLumiMeds +3
82
79
Labs & monitoringReadyRx +11
53
64
FulfillmentReadyRx +18
65
83
Contract termsEven
55
55
LumiMeds · left barReadyRx · right bar

The numbers

MetricLumiMedsReadyRx
WeighScore68.6/10067.8/100
GradeCC
Scorecard rank#143#156
Semaglutide$133/mo (starting dose, compounded)$179/mo (starting dose, compounded)
Tirzepatide$133/mo (starting dose, compounded)$255/mo (starting dose, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
LumiMeds

Graded #143 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
ReadyRx

Graded #156 · C

Strengths

  • LegitScript Certified — verifiable via the badge link in the footer
  • Batch lab testing covers the right QA metrics for injectables: potency, sterility, pH, and endotoxicity
  • Pricing shown publicly: $179/mo semaglutide, $255/mo tirzepatide

Where it loses points

  • Pharmacy partners not named — only described as 'FDA-registered compounding pharmacies'
  • Clinicians described as licensed and board-certified, but no names or credentials published
  • 5,000+ member figure comes from a directory listing, not an independent audit

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard